- Home
- TYG vs MPLT Comparison
TYG vs MPLT Comparison
Compare TYG & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TYG | MPLT |
|---|---|---|
| Founded | 2003 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 860.2M | 822.2M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | TYG | MPLT |
|---|---|---|
| Price | $40.48 | $17.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $31.00 |
| AVG Volume (30 Days) | 121.9K | ★ 420.9K |
| Earning Date | 02-06-2026 | 12-04-2025 |
| Dividend Yield | ★ 10.71% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.19 | N/A |
| Revenue | ★ $18,090,640.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.88 | ★ N/A |
| Revenue Growth | ★ 32.84 | N/A |
| 52 Week Low | $33.73 | $12.24 |
| 52 Week High | $48.76 | $21.55 |
Technical Indicators
Market Signals| Indicator | TYG | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 31.75 | N/A |
| Support Level | $40.86 | N/A |
| Resistance Level | $42.02 | N/A |
| Average True Range (ATR) | 0.57 | 0.00 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 1.54 | 0.00 |
Price Performance
Historical ComparisonAbout TYG Tortoise Energy Infrastructure Corporation
Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.
About MPLT MapLight Therapeutics Inc.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.